Company / Revenue
Cytosorbents Corp Revenue History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$4.9M
FY2018
5-year range
$4.1M / $15.2M
FY2014-FY2018
Trend
-67.5%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 8 years, ranging from $36,078 in FY2011 to $15M in FY2017.
Based on SEC 10-K filings.
$5M in FY2018 with a 5-year CAGR of +29.7%.
Improved from $4M to $5M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +0.9%
- 5-Year CAGR
- +29.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +29.7%, indicating consistent growth.
- In FY2018, revenue decreased 67.5% year-over-year.
- Peak revenue was recorded in FY2017.
- Lowest revenue in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $4.9M | -67.5% |
| FY2017 | $15.2M | +267.5% |
| FY2016 | $4.1M | -14.0% |
| FY2015 | $4.8M | +16.2% |
| FY2014 | $4.1M | +207.0% |
| FY2013 | $1.3M | +0.0% |
| FY2012 | $1.3M | +3622.3% |
| FY2011 | $36.1K | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026